Trial intelligence / Profile preview

Naloxone for In-Hospital Cardiac Arrest

NCT07806565Phase 3Not yet recruiting

Sponsor
Region Skåne
Start
Jan 2027
Primary completion
Jan 2030
01

Overview

A Phase 3 trial of naloxone in cardiac arrest (SCA), sponsored by Region Skåne. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

naloxone
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on NCT07806565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07806565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call